Facts and Figures: 2.643 Forscher*innenprofile (davon 1587 mit ORCID-ID), 8.846 Forschungsprojekte, 154.924 Publikationen, Posters und Vorträge, 64.574 Volltextlinks (davon Volltext frei zugänglich: > 28.375 (Open Access) )
Aktuelle Zitierungen im Web of Science: 1.999.826, davon 3.913 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 300.307
Strukturiertes Kommunikationstraining mit standardisierten Patient*innen für die antenatale neonatologische Beratung bei drohender Frühgeburt
Projektleitung: Mileder Lukas Peter
Laufzeit: 01.10.2025 - 31.12.2026
Geldgeber: Österreichische Gesellschaft für Kinder- und Jugendheilkunde
Cross Regions 4 Health
Projektleitung: Fandler-Höfler Simon
Laufzeit: 01.10.2025 - 30.09.2028
Geldgeber: Europäische Kommission
Sedik, S; Egger, M; Wolfgruber, S; Salmanton-García, J; Bassetti, M; Mikulska, M; Özenci, V; Arikan-Akdagli, S; Akova, M; Gangneux, JP; Bandera, A; Alastruey-Izquierdo, A; Barac, A; Rautemaa-Richardson, R; de, Jonge, NA; Loughlin, L; Blennow, O; Lanternier, F; Meijer, EFJ; Khanna, N; Garcia-Vidal, C; Dávila-Valls, J; Klimko, N; Khostelidi, SN; White, PL; Akalin, H; Rogers, B; Ruiz, M; García-Rodríguez, J; Akyol, D; Longval, T; Danion, F; Prattes, J; Krause, R; Biswas, SK; Arendrup, MC; Koehler, P; Cornely, OA; Hoenigl, M; Willinger, B; Lockhart, DEA; Martín-Pérez, S; Trauth, J; Van, Praet, J; Talento, AF; Toscano, C; Desoubeaux, G; Tumbarello, M; Goodman, AL; Matos, T; Hammarstroem, H; Scharmann, U; Steinmann, J; Samarkos, M; Narayanan, M; Bicanic, T; Siváková, A; Hamal, P; Poscarme, D; Ruiz, AC, , ECMM, Candida, III, study, group
Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III Study.
J Infect. 2025; 106629
Doi: 10.1016/j.jinf.2025.106629
PubMed
FullText
FullText_MUG
20.10.2025:
Lichtenegger, S; Klugherz, I; Wagner, GE; Michel, J; Mollo, B; Sanogo, A; Diawara, MK; Traore, S; Kodo, HG; Mbangui, MY; Koudika, MH; Sidibé, YD; Dabernig-Heinz, J; Kohler, C; Becker, K; Assig, K; Limmathurotsakul, D; Kohl, M; Jimenez, C; Kanapathipillai, R; Ousley, J; Steinmetz, I
Melioidosis in Mali: a retrospective observational study.
Lancet Glob Health. 2025; 13(11):e1964-e1972
Doi: 10.1016/S2214-109X(25)00317-1
PubMed
FullText
FullText_MUG
18.10.2025:
Byrne, NJ; Koentges, C; Pfeil, K; Lueg, JC; Bakshi, S; Tarkhnishvili, A; Vosko, I; Gollmer, J; Birkle, LC; Rathner, T; Birkle, S; Tang, S; Rau, C; Hoffmann, MM; Odening, KE; Barnes, S; Wilson, LS; Ljubojevic-Holzer, S; Wallner, M; von, Lewinski, D; Rainer, P; Sedej, S; Sourij, H; Bode, C; Wende, AR; Zirlik, A; Bugger, H
Cardiomyocyte-Specific Deletion of Sirtuin 5 Accelerates the Development of Heart Failure Upon Dysregulating Purine Metabolism.
Acta Physiol (Oxf). 2025; 241(11):e70120
Doi: 10.1111/apha.70120
PubMed
FullText
FullText_MUG
17.10.2025:
Zappon, E; Azzolin, L; Gsell, MAF; Thaler, F; Prassl, AJ; Arnold, R; Gillette, K; Kariman, M; Manninger, M; Scherr, D; Neic, A; Urschler, M; Augustin, CM; Vigmond, EJ; Plank, G
An efficient end-to-end computational framework for the generation of ECG calibrated volumetric models of human atrial electrophysiology.
Med Image Anal. 2025; 107(Pt B): 103822
Doi: 10.1016/j.media.2025.103822
PubMed
FullText
FullText_MUG
16.10.2025:
von, Hoff, K; Obrecht-Sturm, D; Ghasemi, DR; Wenning, J; Mynarek, M; Gerber, NU; Benesch, M; Juhnke, BO; Bison, B; Warmuth-Metz, M; Timmermann, B; Faldum, A; Tippelt, S; Fleischhack, G; Grotzer, M; Driever, PH; Beilken, A; Ebinger, M; Graf, N; Frühwald, MC; Schmid, I; Slavc, I; Koch, A; Bergmann, M; Hagel, C; Coras, R; Blümcke, I; Reifenberger, G; Felsberg, J; Keyvani, K; Harter, PN; Prinz, M; Staszewski, O; Acker, T; Stadelmann-Nessler, C; Hartmann, C; von, Deimling, A; Sommer, C; Hasselblatt, M; Riemenschneider, MJ; Monoranu, CM; Rushing, E; Haberler, C; Kool, M; Sill, M; Pfister, SM; Schüller, U; Pietsch, T; Kortmann, RD; Kwiecien, R; Witt, H; Pajtler, KW; Rutkowski, S, , German, Austrian, and, Swiss, HIT-Network
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.
Neuro Oncol. 2025;
Doi: 10.1093/neuonc/noaf218
PubMed
FullText
FullText_MUG
Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.
Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).
Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.
1 This analysis considered only publications categorized as full papers/original articles.
2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.